Sort
261,768 grants matching “gene therapy”
Neuronal and Progenitor/Stem Cell Function During Salivary Gland Development
$1,149,411Matthew Hoffman · National Institute Of Dental & Craniofacial Research · ZIA · FY2017 · DE
Growth Factor/Extracellular Matrix Interactions During Branching Morphogenesis
$1,149,411Matthew Hoffman · National Institute Of Dental & Craniofacial Research · ZIA · FY2017 · DE
ONCOGENES IN CANCER ETIOLOGY AND PROGRESSION
$1,149,341Thomas Jefferson University · P01 · FY2003 · CA
Gene Therapy for Metabolic Disorders
$1,149,228Chester B Whitley · University Of Minnesota · P01 · FY2011 · HD
Project 2: Molecular Signatures of West Nile virus susceptibility
$1,149,216Ruth R Montgomery · Yale University · U19 · FY2021 · AI
Drug development for tuberous sclerosis complex and other pediatric epileptogenic diseases using neurovascular and cardiac microphysiological models
$1,149,180John Peter Wikswo · Vanderbilt University · UH3 · FY2021 · TR
A 3D IN VITRO DISEASE MODEL OF ATRIAL CONDUCTION
$1,149,158Steven Carl George · University Of California At Davis · UG3 · FY2017 · HL
Mechanism, Regulation and Application of miRNA pathway in cancer
$1,149,001Shuo Gu · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
CHEETAH Center for the Structural Biology of HIV Infection, Restriction, and Viral Dynamics
$1,148,897Owen W. Pornillos · University Of Utah · U54 · FY2023 · AI
The Impact of HIV Infection on Immunologic, Transcriptomic, and Metabolomic Signatures of Medication-Assisted Therapy for Opioid Addiction
$1,148,831Sandra Ann Springer · Yale University · R01 · FY2019 · DA
The Impact of HIV Infection on Immunologic, Transcriptomic, and Metabolomic Signatures of Medication-Assisted Therapy for Opioid Addiction
$1,148,831Sandra Ann Springer · Yale University · R01 · FY2017 · DA
The Impact of HIV Infection on Immunologic, Transcriptomic, and Metabolomic Signatures of Medication-Assisted Therapy for Opioid Addiction
$1,148,831Sandra Ann Springer · Yale University · R01 · FY2020 · DA
PRINT: Nanoparticles: "Calibration Quality" Nano-tools for Studying the Effect of
$1,148,760Joseph M Desimone · Univ Of North Carolina Chapel Hill · U54 · FY2010 · CA
Protein Expression Facility
$1,148,759Robert Petrovich · National Institute Of Environmental Health Sciences · ZIC · FY2025 · ES
Developing Novel Therapies for High Risk Pediatric Cancers
$1,148,695Javed Khan · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Development of CA-IL-12 for Triple Negative Breast Cancer
$1,148,542Edward J Filardo · Cytonus Therapeutics, Inc. · R44 · FY2023 · CA
More Complete Assessment of DNA Variation in Age-Related Macular Degeneration
$1,148,497Goncalo Rocha Abecasis · University Of Michigan At Ann Arbor · R01 · FY2014 · EY
Clinical and Behavioral Studies of Malformation
$1,148,479Leslie Biesecker · National Human Genome Research Institute · ZIA · FY2017 · HG
Chloride fluxes in organellar membranes
$1,148,389Joseph A Mindell · National Institute Of Neurological Disorders And Stroke · ZIA · FY2021 · NS
MITOCHONDRIAL ETIOLOGIES OF PARKINSON'S DISEASE
$1,148,361University Of Virginia Charlottesville · P50 · FY2003 · NS
Unlocking evolutionarily latent immune functions for treating disease
$1,148,267Brenda L. Bass · University Of Utah · R01 · FY2021 · CA
Controlling Hematopoietic Lineage Commitment from ESC to Platelets
$1,148,231Beverly J Torok-Storb · Fred Hutchinson Cancer Research Center · U01 · FY2010 · HL
Studies of Human T Regulatory Cells
$1,148,221Ethan Shevach · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
An Avirulent Arthroconidial Vaccine Candidate to Prevent Human Coccidioidomycosis
$1,148,120John N Galgiani · University Of Arizona · R01 · FY2019 · AI
A single-cell approach to developing non-traditional antibiotics
$1,148,000Zemer Gitai · Princeton University · DP1 · FY2025 · AI